MedPath

Effects of Early Cardiopulmonary Rehabilitation in Patients With Acute Decompensated Heart Failure

Not Applicable
Not yet recruiting
Conditions
Heart Failure
Registration Number
NCT07155421
Lead Sponsor
Izmir Bakircay University
Brief Summary

Acute decompensated heart failure (ADHF) is a severe condition characterized by rapid deterioration of cardiac function, leading to impaired oxygen delivery and multi-organ dysfunction. ADHF often results in reduced physical and respiratory capacity, greater dependence on oxygen support, difficulty performing daily activities, and prolonged hospital stays. In recent years, early exercise-based cardiopulmonary rehabilitation (CPR) has been introduced as part of heart failure management. Evidence suggests that early CPR improves overall health and cardiac function in heart failure patients. However, data regarding its effects in ADHF remain limited. While some studies indicate that early CPR enhances physical function, its impact on respiratory parameters and clinical outcomes is less well established.

Cardiopulmonary rehabilitation is a multidisciplinary program designed to promote physical, psychological, and social recovery in patients with cardiovascular and pulmonary diseases. It includes exercise training, education, psychosocial support, and behavioral strategies. Early CPR specifically aims to improve cardiovascular and respiratory functions in heart failure patients. Initiating CPR in the early phase of ADHF may accelerate recovery, strengthen cardiopulmonary function, shorten hospitalization, and improve quality of life.

This study aims to evaluate the effects of early CPR on functional capacity, hemodynamic parameters, and respiratory parameters in patients with ADHF.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients hospitalized with a diagnosis of acute decompensated heart failure
  • Being clinically stable
Exclusion Criteria
  • Having diagnosed pulmonary, neurological, renal, liver, gastrointestinal, orthopedic or oncological pathologies
  • Having cardiomyopathy or congestive pericarditis
  • Recent heart surgery in the past 6 months
  • New or suspected thromboembolic event
  • Presence of open wounds, ulcerations or major dermatological diseases in the lower extremities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Functional capacityAt baseline and at hospital discharge, up to 14 days after admission

It will be evaluated using 6-min walk test according to the guideline of American Thoracic Society

Physical performanceAt baseline and at hospital discharge, up to 14 days after admission

It will evaluated using Short Physical Performance Battery.

Secondary Outcome Measures
NameTimeMethod
Maximum inspiratory and expiratory capacityAt baseline and at hospital discharge, up to 14 days after admission

It will be evaluated using incentive spirometer.

Hemodynamic responses to exerciseAt baseline and at hospital discharge, up to 14 days after admission

The change in oxygen saturation before and after exercise will be recorded

Subjective symptom responses to exerciseAt baseline and at hospital discharge, up to 14 days after admission

Subjective symptom responses to exercise will be evaluated by determining changes in the Modified Borg Dyspnea and Fatigue scales before and after exercise.

Trial Locations

Locations (1)

Istanbul University- Cerrahpasa, Cardiology Institute

Istanbul, Turkey (Türkiye)

Istanbul University- Cerrahpasa, Cardiology Institute
Istanbul, Turkey (Türkiye)
Kiymet Muammer, PT, PhD
Contact
+90 552 20585
kiymet.muammer@iuc.edu.tr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.